News and Comments

Good News for Agenus and for Global Blood Therapeutics

  Friday, June 10, 2016

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration with Merck, which is known as MSD outside the United States and Canada.   More...


  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...

Recent Postings



Ariad (ARIA) Theravance (THRX) REGULUS (RGLS) Agenus (AGEN) C4 Therapeutics Ionis (IONS) Alder Biopharmaceuticals (ALDR) Advaxis (ADXS) TOKAI (TKAOI) Biocryst (BCRX) SERES THERAPEUTICS (MCRB) CompuGen (CGEN) Intermune (ITMN) Zerenex Roche (ROCHE) NEKTAR (NKTR)) Anadys (ANDS) CEMPRA (CEMP) Sequenom (SQNM) JUNO (JUNO) Ziofpharm (ZIOP) GUARDIAN HEALTH Revlimid (lenolidamide) Adaptimmune (ADAP) Dynavax (DVAX) AERIE PHARMACEUTICALS Sanofi (SNA) RenenxBio (RGNX) PORTOLA (PTLA) Editas (EDIT) Inovio (INO) Bristol-Myers Squibb (BMY) BIOMARIN (BMRN) Alnylam (ALNY) Auspex (ASPX) Multiple Myeloma Tysabri VANDA (VNDA) Onyx (ONXX) PTC Therapeutics (PTCT) Bellicum (BLCM) Sanofi-Aventis (SAN) Human Genome Sciences (HGSI) Regeneron (REGN) Benlysta (belimumab) Exelixis (EXEL) Intrexon (XON) ABBVIE (ABBV) Merck (MRK) Ridaforolimus INNOVIVA (INVA) Sarepta (SRPT) Global Cell Therapeutics (GBT) IDERA (IDRA) Sangamo (SGMO) SYNTA (SNTA) ADVENTRIX (ANX) AGOS (ARGS) Galena (GALE) Mirati Therapeutics (MRTX) NANTKWEST (NK) Aimmune Therapeutics (AIMT) Spike Therapeutics (ONCE) Roche (RHHBY) ImmunoGen (IMGN) Theravance Bio Pharma (TBPH) Agenus (AGEN ZALTRAP™ Sanofi (SNY) KITE (KITE) galapagos (GLPG) ARCA (ABIO) Dendreon (DNDN) Prolor Biotech (PBTH) ISIS (ISIS) Vitae Pharmaceuticals (VTAE) Trastuzumab-DM1 Abbott Laboratories (ABT) Seattle Genetics (SGEN) Genentech NOVOCURE (NVCR) Jazz Pharmaceuticals (JAZZ) Micromet (MITI) Herceptin Amgen (AMGN) Endometrial Cancer AstraZeneca (AZN) Ocular Therapeutix (OCUL) Gilead (GILD) Human Longevity (HLI) GlaxoSmithKline (GSK) Illumina (ILMN) Incyte (INCY) ARGOS (ARGS) CRISPR Therapeutics (CRSP) SUNESIS PHARMACEUTICALS (SNSS) HALOZYME (HALO) Intercept (ICPT) MODERNA Vertex (VRTX) OSI (OSIP) Elan (ELN) Idenix (IDIX) Valeant Pharmaceuticals International (VRX) Telaprevir Biogen Idec (BIIB) Array Pharmaceuticals (ARRY) Xoma (XOMA) Velcade (bortezomib) Prosensa (RNA) ACADIA (ACAD) KERYX (KERX) Pluristem (PSTI) Rapamune Anacor (ANAC) Cytokinetics (CYTK)